The Differences in the Safety and Tolerability of Immune Checkpoint Inhibitors as Treatment for Non–Small Cell Lung Cancer and Melanoma: Network Meta-Analysis and Systematic Review

Overview of attention for article published in Frontiers in Pharmacology, October 2019

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (66th percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

twitter: 11 X users

Citations

dimensions_citation: 21 Dimensions

Readers on

mendeley: 50 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 13 X posts from 11 X users, with an upper bound of 146,250 followers.

RT @filimasini: The Differences in the Safety and Tolerability of Immune Checkpoint Inhibitors as Treatment for Non–Small Cell Lung Cancer…

15 Dec 2020

Reply Repost Favourite

The Differences in the Safety and Tolerability of Immune Checkpoint Inhibitors as Treatment for Non–Small Cell Lung Cancer and Melanoma: Network Meta-Analysis and Systematic Review https://t.co/QLYdfsOJjB

15 Dec 2020

Reply Repost Favourite

The Differences in the Safety and Tolerability of Immune Checkpoint Inhibitors as Treatment for Non–Small Cell #LungCancer and #Melanoma: Network Meta-Analysis and Systematic Review https://t.co/PtaLAz18Vz #Immunotherapy

06 Dec 2019

Reply Repost Favourite

RT @FrontPharmacol: New Research: The Differences in the Safety and Tolerability of Immune Checkpoint Inhibitors as Treatment for Non–Small…

13 Nov 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 9 additional X posts.